IGF1 and type 2 diabetes mellitus: While, as seen in humans with type 2 diabetes, mIGFREO PEC had reduced serine phosphorylation of eNOS in response to insulin and IGF-1, insulin-stimulated Akt phosphorylation was preserved (Figure 4A through 4C).